SYK and Alzheimer disease: Reducing the phosphorylation levels of Lyn and Syk was confirmed to effectively inhibit the increase in intracellular Ca2+ concentration, cytokine production, and histamine release [55, 60], leading to controlled mast cell degranulation and contributing to the improvement of AD.